Trident Texofab Ltd — Others, 12-05-2025: Corp Action

Trident Texofab Limited has announced a board meeting outcome approving the conversion of 4,08,333 warrants into an equal number of equity shares at Rs. 70 each (including Rs. 60 premium), raising Rs. 2.14 Cr on receipt of the balance payment. These shares have been allotted to non-promoter public category investors on a preferential basis, increasing the company’s paid-up capital to Rs. 13.97 Cr consisting of 1.39 crore shares. Additionally, the board approved a postal ballot notice for appointing Mr. Katwala Sandip Fayeshkumar as a Non-Executive Independent Director and appointed Amarceliya & Associates as the postal ballot scrutinizer.